According to the latest market research conducted by Future Market Insights (FMI), the global mammalian transient protein expression market is poised to exhibit a robust Compound Annual Growth Rate (CAGR) of 8.5% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 697.2 million, with anticipated growth to US$ 1581.6 million by 2033.
Mammalian Transient Protein (MTP) is a pivotal component found in mammalian cells, crucial for various cellular processes including DNA replication, cell division, and protein synthesis. Moreover, MTP plays a crucial role in apoptosis, the programmed cell death process.
Get Sample Report Visit: https://www.futuremarketinsights.com/reports/sample/rep-gb-12807
Key Factors Driving Market Expansion:
- Research and Development Advancements: The market has witnessed substantial growth owing to increased research and development activities coupled with technological advancements, enabling more precise and efficient protein production.
- Rising Demand for Therapeutic Proteins: The escalating demand for therapeutic proteins and other drugs is a significant driver for the mammalian transient protein expression market’s growth.
- Introduction of Innovative Delivery Systems: The advent of novel delivery systems such as nanotechnology and advanced drug-delivery vehicles is facilitating the utilization of mammalian cells for protein expression as therapeutic agents, propelling market growth.
- Demand from Major Industries: Industries like pharmaceuticals and biomedicine are at the forefront of driving market expansion, necessitating substantial volumes of high-quality transient proteins for research and development purposes.
- Clinical Testing and Diagnoses: The unparalleled accuracy of transient proteins renders them indispensable in clinical tests and diagnoses, further augmenting demand and spurring technological advancements in production techniques.
- Utilization in Structural, Therapeutic, and Functional Studies: Mammalian cell expression finds extensive applications in structural, therapeutic, and functional studies, indicating sustained growth potential for the mammalian cell expression market in the foreseeable future.
The future of the global mammalian transient protein expression market appears promising, buoyed by technological innovations, burgeoning demand from various sectors, and the ever-expanding applications of transient proteins in diverse fields.
Customization with Our Report: https://www.futuremarketinsights.com/customization-available/rep-gb-12807
Competitive Landscape:
Significant elements of the mammalian transient protein expression market include product development and market expansion. Consequently, market participants stand to gain a larger share of global revenue in this sector. This trend is anticipated to facilitate the enhancement of product portfolios and the augmentation of market penetration rates.
Key Market Developments:
- In April 2022, Thermo Fisher Scientific introduced the Gibco CTS TrueCut Cas9 Protein, manufactured according to GMP standards.
- In October 2020, Merck KgaA announced an expansion initiative, marked by the inauguration of a new membrane production facility in Darmstadt, Germany. This expansion aimed to bolster the production capacity of Millipore Express® membranes.
Key Companies Profiled:
- Thermofisher Scientific
- Merck KGaA
- Promega Corporation
- Lonza
- Agilent Technologies, Inc.
- Bio-Rad
- Qiagen
- Takara Bio
- HiMedia Laboratories.
- Mirus
- Sino Biological, Inc.
Key Market Segments Covered in Mammalian Transient Protein Expression Industry Research
By Product:
- Instruments
- Expression Vector
- Reagents & Consumables
- Cell Lines
- Chinese Hamster Ovary Cells (CHO)
- Human embryonic kidney 293 (HEK 293) cells
- Others
By Application:
- Bio-production
- Antibody Production
- Therapeutic protein production
- Functional Cell-Based Assays
- Academic Research
- Others
By End User:
- Contract Research Organization
- Biopharmaceutical Companies
- Academic & Research Institutes
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
Request Purchase on Report: https://www.futuremarketinsights.com/checkout/12807
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
